Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Status Completed

Clinical Trial Summary

We will need about 36 participants for this study. Volunteers might be able to participate if: - they have bad noninfectious keratitis - early treatments failed or were not well tolerated Participants will be in the study for about 22 weeks: - 4 weeks for tests to see if the study might be good for them - 12 weeks of treatment with Acthar gel - 4 weeks to wean off Acthar gel and follow-up with the doctor

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Keratitis

Clinical Trial Details

NCT number	NCT04169061
Study type	Interventional
Source	Mallinckrodt
Contact
Status	Completed
Phase	Phase 4
Start date	November 13, 2019
Completion date	December 7, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00513734` - A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill	N/A
Enrolling by invitation	`NCT03436576` - Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye	Phase 3
Recruiting	`NCT06229379` - The Effects of a Large Language Model on Clinical Questioning Skills	N/A
Completed	`NCT01268306` - Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses	Phase 4
Completed	`NCT01028027` - Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis	Phase 3
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Recruiting	`NCT03237936` - Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis	Phase 4
Completed	`NCT00001734` - Screening for NEI Clinical Studies	N/A
Recruiting	`NCT05255107` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers	Phase 2/Phase 3
Recruiting	`NCT05255016` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers	Phase 2/Phase 3
Terminated	`NCT05250583` - Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis	Phase 2
Recruiting	`NCT02865876` - Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis	Phase 3
Terminated	`NCT02116062` - Robotic Surgery of the Ocular Surface	N/A
Recruiting	`NCT00838422` - Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound	N/A
Completed	`NCT00949468` - Microbiological Keratitis in a Countryside City of Brazil	N/A
Completed	`NCT03586505` - Tolerance to Light for Patients Suffering From Keratitis	N/A
Recruiting	`NCT04420962` - Automated Quantitative Ulcer Analysis Study
Completed	`NCT02186431` - Contact Lenses and Infiltrative Keratitis	N/A
Completed	`NCT05538793` - Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
Not yet recruiting	`NCT05689996` - Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis	Phase 3